{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:28:13Z","timestamp":1774679293302,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101153","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:40:58Z","timestamp":1774136458000},"page":"101153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era\u201d"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3090-127X","authenticated-orcid":false,"given":"Tala","family":"Najdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Richa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Chamieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toufic","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fares","family":"Azoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Harmouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hampig Raphael","family":"Kourie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.ctro.2026.101153_b0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semcancer.2022.04.001","article-title":"Small cell lung cancer: Subtypes and therapeutic implications","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101153_b0010","article-title":"Impact of Brain Metastases on Treatment patterns and Outcomes with First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): a Brief Report","volume":"3","author":"Chen","year":"2022","journal-title":"JTO Clin Res Rep"},{"issue":"10","key":"10.1016\/j.ctro.2026.101153_b0015","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.21037\/jtd-2019-sclc-11","article-title":"Systemic therapy for limited stage small cell lung carcinoma","volume":"12","author":"Noronha","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ctro.2026.101153_b0020","doi-asserted-by":"crossref","unstructured":"Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G. Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2022 Dec 1;1868(12):166557.","DOI":"10.1016\/j.bbadis.2022.166557"},{"issue":"7","key":"10.1016\/j.ctro.2026.101153_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic Cranial Irradiation for patients with Small-Cell Lung Cancer in complete Remission","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ctro.2026.101153_b0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ctro.2026.101153_b0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2026.101153_b0040","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2014.57.3105","article-title":"Chemotherapy with or without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: a Randomized, Double-blind, Placebo-Controlled phase II Study-CALGB 30504 (Alliance)","volume":"33","author":"Ready","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101153_b0045","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1016\/j.cllc.2021.03.009","article-title":"Utility of Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer in the MRI Screening Era","volume":"22","author":"Keller","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctro.2026.101153_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102396","article-title":"Re-examining prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis","volume":"67","author":"Gaebe","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.ctro.2026.101153_b0055","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","article-title":"Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214","volume":"86","author":"Gondi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ctro.2026.101153_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.9135","article-title":"Evolving Practice patterns in the use of Prophylactic Cranial Irradiation for Extensive-Stage Small Cell Lung Cancer","volume":"2","author":"Gjyshi","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ctro.2026.101153_b0065","doi-asserted-by":"crossref","unstructured":"Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y, et al. NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. Journal of the National Comprehensive Cancer Network. 2018 Oct 1;16(10):1171\u201382.","DOI":"10.6004\/jnccn.2018.0079"},{"issue":"7","key":"10.1016\/j.ctro.2026.101153_b0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101153_b0075","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.20.03364","article-title":"Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline","volume":"39","author":"Daly","year":"2021","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.ctro.2026.101153_b0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(09)70101-9","volume":"10","author":"Le P\u00e9choux","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101153_b0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2010.05.013","volume":"81","author":"Wolfson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101153_b0090","article-title":"Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy","author":"Yang","year":"2020","journal-title":"JCO"},{"issue":"6","key":"10.1016\/j.ctro.2026.101153_b0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall Survival and PD-L1 Subgroup Analysis of patients with Extensive-Stage Small-Cell Lung Cancer Treated with Atezolizumab, Carboplatin, and Etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"JCO"},{"issue":"23","key":"10.1016\/j.ctro.2026.101153_b0100","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ctro.2026.101153_b0105","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ijrobp.2020.09.020","article-title":"Patterns of Disease Progression after Carboplatin\/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)","volume":"108","author":"Higgins","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10212","key":"10.1016\/j.ctro.2026.101153_b0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101153_b0115","article-title":"First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN): Impact of brain metastases on treatment patterns and outcomes","author":"Chen","year":"2020","journal-title":"JCO"},{"issue":"21","key":"10.1016\/j.ctro.2026.101153_b0120","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or Placebo Plus Etoposide and platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-blind, phase III KEYNOTE-604 Study","volume":"38","author":"Rudin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2026.101153_b0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.20.02212","article-title":"Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451","volume":"39","author":"Owonikoko","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2026.101153_b0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jtho.2024.03.008","article-title":"Tislelizumab Plus platinum and Etoposide Versus Placebo Plus platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): a Multicenter, Double-blind, Placebo-Controlled, Randomized, phase 3 Clinical Trial","volume":"19","author":"Cheng","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"23","key":"10.1016\/j.ctro.2026.101153_b0135","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.3390\/cancers16234122","article-title":"Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of Immunotherapy","volume":"16","author":"Daumas","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ctro.2026.101153_b0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cllc.2023.08.009","article-title":"The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the transition to the Chemo-Immunotherapy Era: a Single Institution Series","volume":"24","author":"Gross","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctro.2026.101153_b0145","unstructured":"SWOG Cancer Research Network. MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) [Internet]. clinicaltrials.gov; 2024 May [cited 2025 Mar 1]. Report No.: NCT04155034. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04155034."},{"key":"10.1016\/j.ctro.2026.101153_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107993","article-title":"PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients","volume":"198","author":"Levy","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctro.2026.101153_b0155","unstructured":"Wang L. Real-world Study of Prophylactic Cranial Irradiation After Immunotherapy Combined With Chemotherapy for Extensive-stage Small Cell Lung Cancer [Internet]. clinicaltrials.gov; 2021 Sep [cited 2025 Mar 1]. Report No.: NCT04947774. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04947774."},{"key":"10.1016\/j.ctro.2026.101153_b0160","article-title":"Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy","volume":"51","author":"Lone","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101153_b0165","unstructured":"Zhou Z. A Prospective Randomized Controlled Study for Prophylactic Cranial Irradiation After Chemotherapy and Thoracic Radiation Therapy in Patients With Extensive-stage Small Cell Lung Cancer [Internet]. clinicaltrials.gov; 2020 Aug [cited 2025 Mar 1]. Report No.: NCT04535739. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04535739."},{"issue":"11","key":"10.1016\/j.ctro.2026.101153_b0170","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.3390\/curroncol31110501","article-title":"Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: an Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"31","author":"Bruni","year":"2024","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101153_b0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canrad.2019.10.001","article-title":"Meta-analysis of prophylactic cranial irradiation or not in treatment of extensive-stage small-cell lung cancer: the dilemma remains","volume":"24","author":"Wen","year":"2020","journal-title":"Cancer\/radioth\u00e9rapie"},{"issue":"7","key":"10.1016\/j.ctro.2026.101153_b0180","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101153_b0185","unstructured":"Aizer AA, Tanguturi SK, Shi DD, Catalano PJ, Shin KY, Ricca I, et al. Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial. J Clin Oncol. 2025 Jul 11;JCO2500056."},{"issue":"5","key":"10.1016\/j.ctro.2026.101153_b0190","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijrobp.2021.04.049","article-title":"Cost-Effectiveness of Prophylactic Cranial Irradiation Versus MRI Surveillance for Extensive-Stage Small Cell Lung Cancer","volume":"111","author":"Kim","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101153_b0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2010.29.6053","article-title":"Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis","volume":"29","author":"Sun","year":"2011","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.ctro.2026.101153_b0200","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.ctro.2026.101153_b0205","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): a GICOR-GOECP-SEOR Study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101153_b0210","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 Randomized Trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctro.2026.101153_b0215","doi-asserted-by":"crossref","unstructured":"Zeng H, Schagen SB, Hendriks LEL, S\u00e1nchez-Benavides G, Jaspers JPM, Manero RM, et al. Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials. Lung Cancer [Internet]. 2025 Jan 1 [cited 2025 Sep 16];199. Available from: https:\/\/www.lungcancerjournal.info\/article\/S0169-5002(24)00570-1\/fulltext.","DOI":"10.1016\/j.lungcan.2024.108036"},{"key":"10.1016\/j.ctro.2026.101153_b0220","year":"2024","journal-title":"ResearchGate [internet]"},{"issue":"10","key":"10.1016\/j.ctro.2026.101153_b0225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal Avoidance during Whole-Brain Radiotherapy Plus Memantine for patients with Brain Metastases: phase III Trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101153_b0230","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101153_b0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jtho.2024.11.011","article-title":"Prophylactic Cranial Irradiation for patients with SCLC-A New Perspective in the Immunotherapy Era","volume":"20","author":"Levy","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"Pt 2","key":"10.1016\/j.ctro.2026.101153_b0240","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.semcancer.2022.05.010","article-title":"Molecular subtyping of small cell lung cancer","volume":"86","author":"Liang","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101153_b0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:25:21Z","timestamp":1774671921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S2405630826000480"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101153","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era\u201d","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101153"}}